Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Nature Methods
|
October 12, 2010
Trans-SILAC: sorting out the non-cell-autonomous proteome
Oded Rechavi, Matan Kalman, Yuan Fang, et al.
Clinical & Developmental Immunology
|
December 18, 2012
Characterizing T cells in SCID patients presenting with reactive or residual T lymphocytes
Atar Lev, Amos J Simon, Luba Trakhtenbrot, et al.
Frontiers in Immunology
|
July 25, 2017
Ras Signaling Inhibitors Attenuate Disease in Adjuvant-Induced Arthritis <i>via</i> Targeting Pathogenic Antigen-Specific Th17-Type Cells
Morad Zayoud, Victoria Marcu-Malina, Einav Vax, et al.
The Journal of Clinical Investigation
|
January 26, 2005
An affinity/avidity model of peripheral T cell regulation
Hong Jiang, Yilun Wu, Bitao Liang, et al.
Clinical Immunology (Orlando, Fla.)
|
May 6, 2008
Synovial VLA-1+ T cells display an oligoclonal and partly distinct repertoire in rheumatoid and psoriatic arthritis
Itamar Goldstein, Amos J Simon, Shomron Ben Horin, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 3, 2012
Ras oncoproteins transfer from melanoma cells to T cells and modulate their effector functions
Helly Vernitsky, Oded Rechavi, Nir Rainy, et al.
The Journal of Allergy and Clinical Immunology
|
September 22, 2009
Reduced central tolerance in Omenn syndrome leads to immature self-reactive oligoclonal T cells
Raz Somech, Amos J Simon, Atar Lev, et al.
Biochemical and Biophysical Research Communications
|
February 19, 2008
MDR1 expression identifies human melanoma stem cells
Gilmor I Keshet, Itamar Goldstein, Orit Itzhaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 26, 2010
TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function
Meital Nagar, Jasmine Jacob-Hirsch, Helly Vernitsky, et al.
Gut
|
June 4, 2010
The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful
Shomron Ben-Horin, Miri Yavzori, Lior Katz, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Nature Methods
|
October 12, 2010
Trans-SILAC: sorting out the non-cell-autonomous proteome
Oded Rechavi, Matan Kalman, Yuan Fang, et al.
Clinical & Developmental Immunology
|
December 18, 2012
Characterizing T cells in SCID patients presenting with reactive or residual T lymphocytes
Atar Lev, Amos J Simon, Luba Trakhtenbrot, et al.
Frontiers in Immunology
|
July 25, 2017
Ras Signaling Inhibitors Attenuate Disease in Adjuvant-Induced Arthritis <i>via</i> Targeting Pathogenic Antigen-Specific Th17-Type Cells
Morad Zayoud, Victoria Marcu-Malina, Einav Vax, et al.
The Journal of Clinical Investigation
|
January 26, 2005
An affinity/avidity model of peripheral T cell regulation
Hong Jiang, Yilun Wu, Bitao Liang, et al.
Clinical Immunology (Orlando, Fla.)
|
May 6, 2008
Synovial VLA-1+ T cells display an oligoclonal and partly distinct repertoire in rheumatoid and psoriatic arthritis
Itamar Goldstein, Amos J Simon, Shomron Ben Horin, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 3, 2012
Ras oncoproteins transfer from melanoma cells to T cells and modulate their effector functions
Helly Vernitsky, Oded Rechavi, Nir Rainy, et al.
The Journal of Allergy and Clinical Immunology
|
September 22, 2009
Reduced central tolerance in Omenn syndrome leads to immature self-reactive oligoclonal T cells
Raz Somech, Amos J Simon, Atar Lev, et al.
Biochemical and Biophysical Research Communications
|
February 19, 2008
MDR1 expression identifies human melanoma stem cells
Gilmor I Keshet, Itamar Goldstein, Orit Itzhaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 26, 2010
TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function
Meital Nagar, Jasmine Jacob-Hirsch, Helly Vernitsky, et al.
Gut
|
June 4, 2010
The immunogenic part of infliximab is the F(ab')2, but measuring antibodies to the intact infliximab molecule is more clinically useful
Shomron Ben-Horin, Miri Yavzori, Lior Katz, et al.
Page
of 4